Haemonetics
260 hedge funds and large institutions have $4.49B invested in Haemonetics in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 94 increasing their positions, 97 reducing their positions, and 54 closing their positions.
269% more call options, than puts
Call options by funds: $3.55M | Put options by funds: $962K
2.17% more ownership
Funds ownership: 98.39% → 100.56% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 97
7% less funds holding
Funds holding: 279 → 260 (-19)
11% less capital invested
Capital invested by funds: $5.07B → $4.49B (-$581M)
30% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$89.9M |
| 2 |
BlackRock
New York
|
+$32.6M |
| 3 |
HM
HealthCor Management
New York
|
+$23.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$19.6M |
| 5 |
Neuberger Berman Group
New York
|
+$18.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$25.1M |
| 2 |
CCI
Columbus Circle Investors
|
-$24.7M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$22.3M |
| 4 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
-$20.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$17.7M |
HAE Hedge Fund Activity: Q1 2019 in Review
260 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2019, worth a combined $4.49B — down 11% from $5.07B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of HAE and 38 opened new positions — a net loss of 16 holders — while 97 trimmed existing stakes and 94 added.
The largest buyer was Wellington Management Group, adding an estimated $89.9M. The largest seller was Acadian Asset Management, cutting an estimated $25.1M.
- 260 institutional investors held Haemonetics (HAE) as of Q1 2019, down from 279 in Q4 2018.
- Funds reported $4.49B of Haemonetics stock for Q1 2019, down 11% quarter-over-quarter.
- 38 funds opened new Haemonetics positions in Q1 2019 and 54 closed out, a net change of -16 holders.
- The largest Haemonetics buyer in Q1 2019 was Wellington Management Group, an estimated $89.9M added.
- The largest Haemonetics seller in Q1 2019 was Acadian Asset Management, an estimated $25.1M sold.
Based on aggregated 13F filings for Q1 2019.